肾下腹主动脉瘤EVAR术后2型内漏栓塞治疗的结果
本研究回顾性分析了2001年4月至2022年8月间48例因EVAR术后2型内漏增大接受经动脉或经腰栓塞的患者,共58次栓塞。主要临床结局为动脉瘤破裂,继发结局包括内漏复发、再栓塞、瘤囊增长≥5 mm和死亡率。临床成功定义为瘤囊直径未增加≥5 mm。结果显示,初次栓塞后瘤囊增长占56.5%,稳定占30.4%,缩小占13.0%;临床成功率为43.5%;4例发生破裂,其中仅1例由孤立性2型内漏引起。内漏复发对临床成功有显著影响,经动脉与经腰途径在瘤囊大小或演变上无差异。
要点
- EVAR术后2型内漏栓塞的临床成功率为43.5%,内漏复发显著影响临床成功。
- 初次栓塞后56.5%的患者瘤囊仍增长≥5 mm,仅13.0%缩小。
- 48例中仅1例破裂归因于孤立性2型内漏,经动脉与经腰途径效果无差异。
核心结论
- 在48例患者中,仅1例动脉瘤破裂归因于孤立性2型内漏,临床成功率为43.5%。
- 内漏复发对临床成功有显著影响,但经动脉与经腰栓塞途径在瘤囊大小或演变上无差异。
研究设计与样本
- 回顾性研究,纳入2001年4月至2022年8月因EVAR术后2型内漏增大接受经动脉或经腰栓塞的患者48例,共58次栓塞。
- 收集人口学数据、所用内移植物、AAA和T2EL的影像学数据、栓塞剂、技术(TA或TL)及血管造影结果。
主要发现
- 初次T2EL栓塞后,瘤囊增长≥5 mm占56.5%(n=26),稳定占30.4%(n=14),缩小占13.0%(n=6)。
- 4例患者发生破裂,其中仅1例由孤立性T2EL引起。
- 瘤囊增大对总生存率的影响无统计学意义。
- 性别、肥胖、COPD、糖尿病、高血压、高胆固醇血症、吸烟、技术、栓塞剂及从内漏发现到栓塞的时间等因素与结局无关联。
关键数值与推荐
- 临床成功定义为动脉瘤囊直径未增加≥5 mm。
- 临床成功率为43.5%。
临床怎么用
- 对于EVAR术后增大的2型内漏,栓塞治疗可消除或减少内漏体积,可能预防破裂,且经动脉与经腰途径均可选择。
- 内漏复发与临床成功降低相关,需关注复发监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study is to investigate the effect of transarterial (TA) and translumbar (TL) embolization of a type 2 endoleak (T2EL) after endovascular aneurysm repair (EVAR) of an infrarenal abdominal aortic aneurysm (AAA) on the evolution and rupture of the aneurysmal sac. METHODS: A retrospective study was conducted including patients who underwent TA or TL embolization for a growing T2EL after EVAR from April 2001 to August 2022. Demographic data, used endograft, radiological data of the AAA and T2EL, embolization agents, techniques (TA or TL approach), and angiographical outcomes were collected from 48 patients with a total of 58 embolizations. The primary clinical outcome was rupture of the AAA. Secondary outcomes included T2EL recurrence, re-embolization of T2EL, aneurysm sac growth (≥5 mm), and mortality. Clinical success was defined as the absence of a 5 mm or greater increase in the aneurysm sac diameter. RESULTS: After primary T2EL embolizations, an increase in aneurysm sac was seen in 56.5% (n = 26), stability in 30.4% (n = 14), and regression in 13.0% (n = 6). Recurrence of T2EL had a significant impact on clinical success. No difference in sac size or evolution after the TA and TL embolization was noted. Rupture was found in 4 patients, but in only 1 patient it was caused by an isolated T2EL. The effect of increase in aneurysm sac size on overall survival was not statistically significant. Additionally, no associations were observed between the outcome and clinical factors including gender, obesity, chronic obstructive pulmonary disease, diabetes, hypertension, hypercholesterolemia, smoking, technique, used embolic agents, and time from endoleak onset to embolization. CONCLUSION: In this retrospective study, 1 AAA rupture was attributable to an isolated T2EL out of 48 patients, with a clinical success rate of 43.5%.Clinical ImpactAlthough the impact of a type 2 endoleak (T2EL) on the outcome of an endovascular repaired abdominal aortic aneurysm is not yet clarified, in daily practice, the endovascular embolization is considered as a safe and effective option. Elimination or reduction of the volume of the endoleak can be obtained and can probably prevent aortic rupture, which is reassuring for the treating physician and the patient. The embolization of the T2EL reduces the need for extra imaging or hospitalizations, lowers the risk of complications and minimizes healthcare costs. This study contributes to the knowledge and treatment of T2EL, supporting clinicians in making better informed decisions, ultimately optimizing patient care. Moreover, this research found no outcome differences between the embolization techniques.
引用
- Steenbeke M, Moreels N, Vermassen F, et al. Outcome of Embolization of an Endoleak Type 2 After Placement of an Endoprosthesis for an Infrarenal Aorta Aneurysm. J Endovasc Ther. 2025. PMID: 40832980. doi:10.1177/15266028251363477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。